Tag Archives: Forward Looking Statements Statements

Business, Finance, Occupation & Industry

Helix Announces BP Contract for Q5000

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Helix Announces BP Contract for Q5000

HOUSTON–(BUSINESS WIRE)– Helix Energy Solutions Group, Inc. (NYS: HLX) announced today that it has entered into a five-year contract with BP to provide well intervention services to BP in the US Gulf of Mexico with Helix’s deepwater well intervention semisubmersible vessel, the Q5000, currently being constructed in Singapore. The contract is for a minimum 270 days each year and is expected to commence between April and August 2015 following the delivery of the vessel from the shipyard. The contract also includes a first right of refusal for additional days each year and an option to extend for two successive one-year terms.

“We appreciate the confidence BP has shown in our Company’s well intervention services, and look forward to this integral step in further executing our business strategy,” said Helix President and Chief Executive Officer Owen Kratz.

About Helix

Helix Energy Solutions Group, headquartered in Houston, Texas, is an international offshore energy company that provides key life of field services to the energy market. For more information about Helix, please visit our website at www.HelixESG.com.

Forward-Looking Statements

Statements included in this news release regarding the timing of commencement of the contract, Helix’s strategy and other statements that are not historical facts are forward-looking statements. These statements involve risks and uncertainties including, but not limited to the performance of contracts by suppliers, customers and partners; actions by governmental and regulatory authorities; operating hazards and delays; employee management issues; local, national and worldwide economic conditions; uncertainties inherent in the exploration for and development of oil and gas; complexities of global political and economic developments; geologic risks, volatility of oil and gas prices; market conditions, and other risks described from time to time in our reports filed with the Securities and Exchange Commission (“SEC“), including the Company’s most recently filed Annual Report on Form 10-K and in the Company’s other filings with the SEC, which are available free of charge on the SEC‘s website at www.sec.gov. We assume no obligation and do not intend to update these forward-looking statements except as required by law.

Helix Energy Solutions Group, Inc.
Terrence Jamerson, 281-618-0400
Director, Finance & Investor Relations

KEYWORDS:   United States  North America  Texas

INDUSTRY KEYWORDS:

The article <a target=_blank …read more

Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Thomas Properties Group Announces Sale of Suburban Austin Properties

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Thomas Properties Group Announces Sale of Suburban Austin Properties

LOS ANGELES–(BUSINESS WIRE)– Thomas Properties Group, Inc. (NAS: TPGI) today announced that its affiliate, TPG/CalSTRS Austin, LLC, has completed the sale of three office properties containing a total of 517,974 rentable square feet in suburban northwest Austin, Texas. The properties are Westech 360, Park Centre and Great Hills Plaza, all of which were unencumbered by debt. The sales price for the properties was $76.0 million, which after closing adjustments and prorations, resulted in net proceeds to TPG/CalSTRS Austin, LLC of $73.0 million. Thomas Properties Group‘s share of the net proceeds is $24.3 million.

James A. Thomas, Chairman and CEO noted, “The closing of this transaction is the culmination of our original plan for the 10 building Austin portfolio, which included our disposition of the suburban properties, allowing us to concentrate on the ownership and operation of the five Class A high rise buildings in downtown Austin. This sale is also a further step in completing our corporate strategic plan of generating cash from the sale of non-core operating assets that have achieved their maximum value in our portfolio for reinvestment in first class office buildings that generate recurring cash flow, with our focus on markets in western US cities.”

About Thomas Properties Group

Thomas Properties Group, Inc., based in Los Angeles, is a full-service real estate company that owns, acquires, develops and manages primarily office, as well as mixed-use and residential properties on a nationwide basis. The company’s primary areas of focus are the acquisition and ownership of premier properties, both on a consolidated basis and through its strategic joint ventures, property development and redevelopment, and property management and leasing activities. For more information about Thomas Properties Group, Inc., please visit www.tpgre.com.

Forward Looking Statements

Statements made in this press release that are not historical may contain forward-looking statements. Although TPGI believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, these statements are subject to numerous risks and uncertainties. Factors that could cause actual results to differ materially from TPGI‘s expectations include actual and perceived trends in various national and economic conditions that affect global and regional markets for commercial real estate services (including interest rates), the availability of credit and equity investors to finance commercial real estate transactions, our ability to enter into …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

ACT's Chief Scientific Officer Dr. Robert Lanza to Deliver the Nerem Lecture 2013 at the 17th Annual

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

ACT’s Chief Scientific Officer Dr. Robert Lanza to Deliver the Nerem Lecture 2013 at the 17 th Annual Hilton Head Workshop

Leading Scientists, Engineers, Clinicians & Industry Participants to Discuss Cutting Edge Research in the Regenerative Medicine Field

MARLBOROUGH, Mass.–(BUSINESS WIRE)– Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that its chief scientific officer, Robert Lanza, M.D., will be delivering the “Robert M. Nerem Lecture” at the 17th Annual Hilton Head Workshop, “Regenerative Medicine: Technologies Enabling Novel Therapies” being held on Hilton Head Island, March 20-23. The goal of the workshop is to bring the community together in an intimate, “Gordon-conference style” forum to share the latest insights and discoveries in this rapidly progressing field. Dr. Lanza’s Lecture, entitled “The Use of Pluripotent Stem Cells in Regenerative Medicine,” will take place on Saturday, March 23, at 5:00p.m. EDT.

Dr. Lanza’s presentation is the second annual Nerem Lecture, with the first having been delivered last year by George Q. Daley, M.D., Ph.D. Samuel E. Lux IV Professor of Hematology/Oncology and Director of the Stem Cell Transplantation Program at Children’s Hospital Boston, and Professor at Harvard Medical School.

The conference brings together leading researchers in the field of regenerative medicine, along with other scientists, engineers, and clinicians, including speakers from Harvard University, Stanford, Cornell, Duke, UCLA, and the University of Pennsylvania, among others.

About Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc., is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit www.advancedcell.com.

Forward-Looking Statements

Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words “will,” “believes,” “plans,” “anticipates,” “expects,” “estimates,” and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Universal Power Group Announces Fourth Quarter and Full Year 2012 Earnings Release and Conference Ca

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Universal Power Group Announces Fourth Quarter and Full Year 2012 Earnings Release and Conference Call

CARROLLTON, Texas–(BUSINESS WIRE)– Universal Power Group, Inc. (NYSE MKT: UPG), a Texas-based distributor and supplier of batteries and related power accessories and a third-party logistics provider, today announced that it will report its fourth quarter and full year 2012 financial results before the market opens on Thursday, March 28, 2013.

Universal Power Group will also host an investor conference call on Thursday, March 28, 2013 at 11:30 a.m. ET (10:30 a.m. CT) to discuss its financial results. Interested parties may access the conference call by dialing 1.800.322.2803; passcode 97547021. The conference call will also be webcast live at www.upgi.com and through the Thomson StreetEvents Network. Individual investors can listen to the call at www.earnings.com, Thomson’s individual investor portal. Institutional investors can access the webcast via Thomson StreetEvents (www.streetevents.com), a password-protected event management site.

A replay of the conference call will be made available through April 4, 2013 by calling 1.888.286.8010, passcode 76646056, and an archived webcast will be available at www.upgi.com.

About Universal Power Group, Inc.

Universal Power Group, Inc. (NYSE MKT: UPG) is a leading supplier and distributor of batteries and power accessories, and a provider of supply chain and other value-added services. UPG‘s product offerings include proprietary brands of industrial and consumer batteries of all chemistries, chargers, jump-starters, 12-volt accessories, and solar and security products. UPG‘s supply chain services include procurement, warehousing, inventory management, distribution, fulfillment and value-added services such as sourcing, battery pack assembly and coordinating battery recycling efforts, as well as product development. For more information, please visit the UPG website at www.upgi.com.

Forward-Looking Statements

Statements in this press release that are not statements of historical or current fact constitute “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause the Company’s actual operating results to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as “believes,” “belief,” “expects,” “expect,” “intends,” “intend,” “anticipate,” “anticipates,” “plans,” “plan,” to be uncertain and forward-looking. The forward-looking statements contained herein are also subject …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

General Moly Announces Financing Update

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

General Moly Announces Financing Update

LAKEWOOD, Colo.–(BUSINESS WIRE)– General Moly, Inc. (the “Company”) (NYSE MKT: GMO)(TSX: GMO), a U.S.-based molybdenum mineral development, exploration and mining company has been informed that legal counsel has suspended work on the $665 million Chinese sourced Term Loan that is currently being negotiated with China Development Bank (“CDB”) for the development of the Mt. Hope Project until further notice. This suspension of activities relates to media reports that Mr. Liu Han, Chairman of Sichuan Hanlong Group (“Hanlong”) has reportedly been detained by Chinese authorities. Hanlong or an affiliate is obligated to arrange and guarantee the Term Loan, throughout its life.

General Moly is seeking clarification from Hanlong as to the implications for the Company and will advise the market should these enquiries render any relevant information.

Bruce D. Hansen, Chief Executive Officer of General Moly, said “We have been making good progress negotiating the Term Loan and are disappointed that this work has been suspended until further clarification is received from Hanlong. We hope to re-establish Term Loan negotiations with Hanlong and CDB in the near-term, but will concurrently assess other financing alternatives.”

* * * *

General Moly is a U.S.-based molybdenum mineral development, exploration and mining company listed on the NYSE MKT (formerly the NYSE AMEX) and the Toronto Stock Exchange under the symbol GMO. Our primary asset, our interest in the Mt. Hope Project located in central Nevada, is considered one of the world’s largest and highest grade molybdenum deposits. Combined with our second molybdenum property, the Liberty project that is also located in central Nevada, our goal is to become the largest pure play primary molybdenum producer in the world. For more information on the Company, please visit our website at http://www.generalmoly.com.

Forward-Looking Statements

Statements herein that are not historical facts are “forward-looking statements” within the meaning of Section 27A of the Securities Act, as amended and Section 21E of the Securities Exchange Act of 1934, as amended and are intended to be covered by the safe harbor created by such sections. Such forward-looking statements involve a number of risks and uncertainties that could cause actual results to differ materially from those projected, anticipated, expected, or implied by the Company. These risks and uncertainties include, but are not limited to, metals price and production volatility, global economic conditions, currency fluctuations, increased production costs and variances in ore grade or recovery …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Intermec Stockholders Approve Adoption of Merger Agreement with Honeywell

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Intermec Stockholders Approve Adoption of Merger Agreement with Honeywell

EVERETT, Wash.–(BUSINESS WIRE)– Intermec, Inc. (NYSE:IN; “Intermec”) today announced that Intermec stockholders voted overwhelmingly to approve the adoption of the previously announced Agreement and Plan of Merger between Intermec, Honeywell International Inc. (“Honeywell”), and Hawkeye Merger Sub Corp., a wholly owned subsidiary of Honeywell (the “Merger Agreement“). Approximately 99% of Intermec’s shares voted at the special meeting of Intermec’s stockholders held earlier today, or approximately 79% of Intermec’s outstanding shares of common stock as of the close of business on January 25, 2013, the record date for the special meeting of stockholders, were voted in favor of the adoption of the Merger Agreement.

Completion of the transaction remains subject to regulatory approvals (including the expiration or termination of the waiting period under the Hart-Scott Rodino Antitrust Improvements Act of 1976, as amended, and the requirements of certain foreign jurisdictions, including the European Commission) and other customary closing conditions. Intermec continues to expect that the transaction will close in the second quarter of 2013.

About Intermec

Intermec Inc. (NYS: IN) is the workflow performance company. We design the leading data capture and information management solutions at the interface between mobile workers, assets, and customers. For more information about Intermec, visit www.intermec.com (which website is not incorporated herein by reference).

Forward-Looking Statements

Statements made in this press release and related statements that express Intermec’s or our management’s intentions, hopes, indications, beliefs, expectations, guidance, estimates, forecasts or predictions of the future constitute forward-looking statements, as defined by the Private Securities Litigation Reform Act of 1995, and relate to matters that are not historical facts. The forward-looking statements contained herein include, without limitation, statements regarding: the potential acquisition of Intermec by Honeywell; the receipt of regulatory approval for the potential merger transaction; and the anticipated timing of the closing of the potential merger transaction, if at all. When used in this document and in documents it refers to, the words “anticipate,” “believe,” “will,” “intend,” “project” and “expect” and similar expressions as they relate to us or our management are intended to identify such forward- looking statements. These statements represent beliefs and expectations only as of the date they were made. We may elect to update forward-looking statements, but we expressly disclaim any obligation to do so, even if our beliefs and …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Derma Sciences to Present at the 25th Annual ROTH Conference

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Derma Sciences to Present at the 25 th Annual ROTH Conference

PRINCETON, N.J.–(BUSINESS WIRE)– Derma Sciences, Inc. (the “Company”) (NAS: DSCI) , a medical device and pharmaceutical company focused on advanced wound care, announced today that the Company will be presenting at the 25th Annual ROTH Conference on Tuesday, March 19 at 12:00 p.m. Pacific Time. The conference will be held at The Ritz-Carlton in Dana Point, Calif., from March 17 to 20, 2013.

To listen and view the presentation investors may visit the investor relations section of Derma Sciences‘ website at www.dermasciences.com. An archived copy of the presentation will also be available on Derma Sciences‘ website.


About Derma Sciences, Inc.

Derma Sciences is a medical technology company focused on three segments of the wound care marketplace: pharmaceutical wound care products, advanced wound care dressings to address chronic wounds, including diabetic ulcers and traditional dressings. The Company has begun Phase 3 clinical trials in diabetic foot ulcer healing with DSC127, based on excellent Phase 2 data. Its MEDIHONEY® product is the leading brand of honey-based dressings for the management of wounds and burns. The product has been shown to be effective in a variety of indications, and was the focus of a positive large-scale, randomized controlled trial involving 108 subjects with leg ulcers. TCC-EZ™ is its gold-standard total contact casting system for diabetic foot ulcers. Other novel products introduced into the $14 billion global wound care market include XTRASORB® for better management of wound exudate, and BIOGUARD® for infection prevention.

For more information please visit www.dermasciences.com.


Forward-Looking Statements

Statements contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate” or “continue” are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company’s actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release or that are otherwise made by or on behalf of the Company. Factors that …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

71st Common Stock Monthly Dividend Increase Declared by Realty Income

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

71 st Common Stock Monthly Dividend Increase Declared by Realty Income

ESCONDIDO, Calif.–(BUSINESS WIRE)– Realty Income Corporation (Realty Income), The Monthly Dividend Company®, (NYS: O) , today announced its board of directors has declared an increase in the company’s common stock monthly cash dividend to $0.1812292 per share from $0.1809167 per share. The dividend is payable on April 15, 2013 to shareholders of record as of April 1, 2013. This is the 71st dividend increase since Realty Income went public in 1994. The new monthly dividend amount represents an annualized dividend amount of approximately $2.175 per share as compared to the previous annualized dividend amount of $2.171 per share. The company continues its long-term policy of declaring and paying dividends on a monthly, rather than on a quarterly, basis. To view a history of Realty Income‘s dividend increases, refer to the chart below or visit the company’s website at www.realtyincome.com.

Tom A. Lewis, Chief Executive Officer of Realty Income, commented, “We are pleased that our operations allow us to once again increase the amount of the dividend we pay to our shareholders. With the payment of the April dividend, we will have made 513 consecutive monthly dividend payments.”

About the Company

Realty Income, The Monthly Dividend Company®, is a New York Stock Exchange real estate company dedicated to providing shareholders with dependable monthly income. To date the company has declared 513 consecutive common stock monthly dividends throughout its 44-year operating history and increased the dividend 71 times since Realty Income‘s listing on the New York Stock Exchange in 1994. The monthly income is supported by the cash flow from over 3,500 properties owned under long-term lease agreements with regional and national retail chains and other commercial enterprises. The company is an active buyer of net-leased properties nationwide. Additional information about the company can be obtained from the corporate website at www.realtyincome.com or www.twitter.com/realtyincome.

Forward-Looking Statements

Statements in this press release that are not strictly historical are “forward-looking” statements. Forward-looking statements involve known and unknown risks, which may cause the company’s actual future results to differ materially from expected results. These risks include, among others, general economic conditions, local real estate conditions, tenant financial health, the availability of capital to finance planned growth, continued volatility and uncertainty in the credit markets and broader financial markets, property acquisitions and the timing of …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

ACADIA Pharmaceuticals to Present at the 25th Annual ROTH Conference on March 19, 2013

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

ACADIA Pharmaceuticals to Present at the 25 th Annual ROTH Conference on March 19, 2013

SAN DIEGO–(BUSINESS WIRE)– ACADIA Pharmaceuticals Inc. (NAS: ACAD) , a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will present at the 25th Annual ROTH Conference on Tuesday, March 19, 2013, at 10:00 a.m. Pacific Time at The Ritz-Carlton in Laguna Niguel.

A live webcast of ACADIA‘s presentation will be accessible on the company’s website, www.acadia-pharm.com, under the investors section and an archived recording will be available on the website through April 2, 2013.

About ACADIA Pharmaceuticals

ACADIA is a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders. ACADIA has a pipeline of product candidates led by pimavanserin, which is in Phase III development as a potential first-in-class treatment for Parkinson’s disease psychosis. ACADIA also has clinical-stage programs for chronic pain and glaucoma in collaboration with Allergan, Inc. and two advanced preclinical programs directed at Parkinson’s disease and other neurological disorders. All product candidates are small molecules that emanate from discoveries made at ACADIA. ACADIA maintains a website at www.acadia-pharm.com to which ACADIA regularly posts copies of its press releases as well as additional information and through which interested parties can subscribe to receive email alerts.

Forward-Looking Statements

Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements include but are not limited to statements related to the progress and timing of ACADIA‘s drug discovery and development programs, either alone or with a partner, including clinical trials, and the benefits to be derived from ACADIA‘s product candidates, in each case including pimavanserin. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties. Actual events or results may differ materially from those projected in any of such statements due to various factors, including the risks and uncertainties inherent in drug discovery, development and commercialization, and collaborations with others, and the fact that past results of clinical trials may not be indicative of future trial results. For a discussion of these and other factors, please refer to ACADIA‘s annual report on Form 10-K for the year ended December 31, 2012 …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Ares Dynamic Credit Allocation Fund Declares Monthly Distribution of $0.117 Per Share

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Ares Dynamic Credit Allocation Fund Declares Monthly Distribution of $0.117 Per Share

NEW YORK–(BUSINESS WIRE)– Ares Dynamic Credit Allocation Fund (NYS: ARDC) announced the declaration of the monthly distribution of the Fund for the period ending March 31, 2013 of $0.117 per common share, payable as noted below. Based on the Fund’s initial public offering price of $20.00 per share, the distribution represents an annualized yield of 7.02% (calculated by annualizing the distribution amount and dividing it by the IPO share price). Information regarding yield is included for informational purposes only and is not necessarily indicative of future results, the achievement of which cannot be assured.

Ex-Date: March 18, 2013
Record Date: March 21, 2013
Payable Date: March 29, 2013
Per Share Amount: $0.117

About Ares Dynamic Credit Allocation Fund

Ares Dynamic Credit Allocation Fund is a non-diversified, closed-end management company that is externally managed by an affiliate of Ares Management LLC, a global alternative asset manager with approximately $59 billion in committed capital under management as of December 31, 2012. Ares Dynamic Credit Allocation Fund seeks to provide an attractive level of total return primarily through current income and, secondarily, through capital appreciation, by investing in a broad, dynamically-managed portfolio of credit investments.

Forward-Looking Statements

Statements included herein may constitute “forward-looking statements,” which relate to future events or our future performance or financial condition. These statements are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in our filings with the Securities and Exchange Commission. Ares Dynamic Credit Allocation Fund undertakes no duty to update any forward-looking statements made herein.

Ares Dynamic Credit Allocation Fund
630-241-4200
ARDC@destracapital.com
www.aresdc.com

KEYWORDS:   United States  North America  New York

INDUSTRY KEYWORDS:

The article Ares Dynamic Credit Allocation Fund Declares Monthly Distribution of $0.117 Per Share originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

CopyTele Presenting at SeeThruEquity's Spring Microcap Investor Forum

Leave a comment

By Business Wirevia The Motley Fool

Filed under:


CopyTele Presenting at SeeThruEquity’s Spring Microcap Investor Forum

MELVILLE, N.Y.–(BUSINESS WIRE)– CopyTele, Inc. (“CTI“) (OTCBB: COPY) today announced that Robert Berman, CTI‘s President and CEO, will be presenting at the SeeThruEquity Spring Microcap Investor Forum on March 12, 2013 at 10:00 am. The Forum will be held at The Penn Club, located at 30 West 44th Street in New York City. Registration for the forum is available at www.seethruequity.com.

Mr. Berman’s presentation will also be available for viewing via webcast at wsw.com/webcast/seethru2/copy/ on the day of the presentation, and for 90-days following. Audio of the presentation will be available at the CTI website, www.CTIpatents.com. Following the Forum, SeeThruEquity will initiate research coverage of CTI.

SeeThruEquity, LLC is an investment research and corporate access firm that produces high quality research reports on smallcap and microcap companies with less than $1 billion in market capitalization. These companies are typically underserved by the traditional Wall Street analyst establishment. SeeThruEquity is unfettered by any ties to investment banking or trading, and distributes its high impact research as an approved firm for consensus estimates on Thomson Reuters, CapitalIQ, FactSet, Zacks and StockTwits, as well as to its own audience of investors from its corporate website.

For questions regarding this event, CTI or any of CTI‘s patented technologies please contact Ron Tenio at 631-549-5900 x 112 or rtenio@CTIpatents.com.

About CopyTele, Inc.

CopyTele develops and acquires patented technologies for the purposes of patent monetization and patent assertion. The company currently has 4 patent portfolios in the areas of Key Based Encryption, E-Paper® Electrophoretic Display, Nano Field Emission Display (“NFED”), and Micro Electro Mechanical Systems Display (“MEMS”). Additional information is available at www.CTIpatents.com.

Forward-Looking Statements: Statements that are not historical fact may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical facts, but rather reflect CopyTele’s current expectations concerning future events and results. We generally use the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “will” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements, or industry …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Realty Income Corporation Announces Commencement of Public Offering of Common Stock

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Realty Income Corporation Announces Commencement of Public Offering of Common Stock

ESCONDIDO, Calif.–(BUSINESS WIRE)– Realty Income Corporation (Realty Income), The Monthly Dividend Company®, (NYS: O) , today announced that it has commenced an underwritten public offering of 10,000,000 shares of common stock. The Company also plans to grant the underwriters a 30-day option to purchase up to 1,500,000 additional shares of common stock to cover overallotments, if any. The underwriters for the offering are: BofA Merrill Lynch, Morgan Stanley, Wells Fargo Securities, Credit Suisse, Raymond James, RBC Capital Markets, and UBS Investment Bank (joint book-running managers), J.P. Morgan and Jefferies (co-lead managers), Baird, Barclays, BB&T Capital Markets, Citigroup, and Stifel Nicolaus Weisel (senior co-managers), and BNY Mellon Capital Markets, LLC and Piper Jaffray (co-managers).

The Company expects to use the net proceeds from the offering to repay borrowings under its $1.0 billion acquisition credit facility, which were, and will be, used to fund real estate acquisitions.

A preliminary prospectus supplement and final prospectus supplement related to the public offering of these securities has been or will be filed with the Securities and Exchange Commission. Copies of the preliminary prospectus supplement and final prospectus supplement, when available, may be obtained from BofA Merrill Lynch, 222 Broadway, New York, New York 10038, Attn: Prospectus Department or email dg.prospectus_requests@baml.com; or Morgan Stanley, 180 Varick Street, 2nd Floor, New York, New York, 10014, Attn: Prospectus Department, telephone 1.866.718.1649 (toll-free) or email: prospectus@morganstanley.com; or Wells Fargo Securities, Attn: Equity Syndicate Department, 375 Park Avenue, New York, New York 10152, telephone: 1.800.326.5897 or email: cmclientsupport@wellsfargo.com.

These securities are offered pursuant to a Registration Statement that has become effective under the Securities Act. These securities are only offered by means of the prospectus included in the Registration Statement and the preliminary prospectus supplement related to the offering. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction where the offer, solicitation, or sale of these securities would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.


Forward-Looking Statements

Statements in this press release that are not strictly historical are “forward-looking” statements. Forward-looking statements involve known …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2012 Financial Results on March 12,

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2012 Financial Results on March 12, 2013

ACADIA to Host Conference Call and Webcast on Tuesday, March 12, 2013, at 5:00 p.m. Eastern Time

SAN DIEGO–(BUSINESS WIRE)– ACADIA Pharmaceuticals Inc. (NAS: ACAD) , a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will report its financial results for the fourth quarter and year ended December 31, 2012 on Tuesday, March 12, 2013, after the U.S. financial markets close. ACADIA‘s management will host a conference call and webcast on Tuesday, March 12, 2013, at 5:00 p.m. Eastern Time to discuss ACADIA‘s financial results and development programs.

The conference call may be accessed by dialing 866-510-0712 for participants in the U.S. or Canada and 617-597-5380 for international callers (reference passcode 78191729). A telephone replay of the conference call may be accessed through March 26, 2013 by dialing 888-286-8010 for callers in the U.S. or Canada and 617-801-6888 for international callers (reference passcode 59394169). The conference call also will be webcast live on ACADIA‘s website, www.acadia-pharm.com, under the investors section and will be archived there until March 26, 2013.

About ACADIA Pharmaceuticals

ACADIA is a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders. ACADIA has a pipeline of product candidates led by pimavanserin, which is in Phase III development as a potential first-in-class treatment for Parkinson’s disease psychosis. ACADIA also has clinical-stage programs for chronic pain and glaucoma in collaboration with Allergan, Inc. and two advanced preclinical programs directed at Parkinson’s disease and other neurological disorders. All product candidates are small molecules that emanate from discoveries made at ACADIA. ACADIA maintains a website at www.acadia-pharm.com to which ACADIA regularly posts copies of its press releases as well as additional information and through which interested parties can subscribe to receive email alerts.

Forward-Looking Statements

Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements include but are not limited to statements related …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Advanced Cell Technology to Announce Fourth Quarter and Year-end Results on Thursday March 7th

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Advanced Cell Technology to Announce Fourth Quarter and Year-end Results on Thursday March 7 th

Company to Hold Conference Call and Webcast at 4:30 pm Eastern Time to Discuss Results

MARLBOROUGH, Mass.–(BUSINESS WIRE)– Advanced Cell Technology, Inc. (“ACT”;OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that it will report fourth quarter and year-end results for the period ended December 31, 2012 on Thursday, March 7th after the market closes.

The Company will hold a conference call later that day at 4:30 p.m. eastern time to discuss the results and provide a corporate update.

Interested parties may access the call live by dialing (888) 264-3177 and using conference ID 92438156. This event is also being streamed via webcast available at http://us.meeting-stream.com/advancedcelltechnology030413. A replay of the call will also be available via the same link.

About Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc., is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit www.advancedcell.com.

Forward-Looking Statements

Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words “will,” “believes,” “plans,” “anticipates,” “expects,” “estimates,” and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company’s periodic reports, including the report on Form 10-K for the year ended December 31, 2011. Forward-looking statements are based on the beliefs, opinions, and expectations of the company’s management at the time they are …read more
Source: FULL ARTICLE at DailyFinance